NCT06984367 · RECRUITING

A Socio-Technological Intervention in Community-Based Healthcare for Individuals With Mild Cognitive Impairment (DHEAL-COM-MCI)

This trial is testing a socio-technical program for older adults with mild cognitive impairment. The program combines cognitive stimulation exercises, technology tools, and robotics to see whether it can slow cognitive decline and support well-being. It is a Phase NA study, meaning this is a practical intervention trial rather than a traditional drug development phase. Details on exact technology used are limited in the source.

You may qualify if

  • diagnosis of Mild Cognitive Impairment;
  • MoCA ranged 21 - 27;
  • Geriatric Depression Scale 5 items (GDS-5items) ≤ 1

You're excluded if

  • Use of active implantable or non-implantable medical devices;
  • Nickel allergy;
  • Myocardial infarction or stroke within 6 months;
  • Painful arthritis, spinal stenosis, amputation, painful foot lesions, or neuropathy that limits balance and mobility;
  • Uncontrolled hypertension;
  • Pacemaker or implantable cardioverter defibrillator;
  • Metastatic cancer or immunosuppressive therapy;
  • Significant vision or hearing disturbances.

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2025-05-30

View full record on ClinicalTrials.gov

All APOE4 clinical trials